APO Research
Talk to an analyst

APO RESEARCH · REPORT

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026

30 December 2025198 pages

Choose your research edition.

Industry ResearchPIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market include Bioveta, Boehringer Ingelheim, CAVAC, Ceva Santé Animale, HIPRA, Jinyu Bio-Technology, Sinopharm Animal Health Co., Ltd, Zoetis and Harbin Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Company

Bioveta

Boehringer Ingelheim

CAVAC

Ceva Santé Animale

HIPRA

Jinyu Bio-Technology

Sinopharm Animal Health Co., Ltd

Zoetis

Harbin Pharmaceutical Group

Merck

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

CH-1R Strain

PC Strain

Others

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Gilts

Sows

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine industry.

Chapter 3: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 2. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 3. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges Table 4. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Company (2021-2026) Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company, Product Type & Application Table 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of CH-1R Strain Table 18. Significant Companies of PC Strain Table 19. Significant Companies of Others Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Type (2021-2026) Table 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Type (2027-2032) Table 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type (2021-2026) Table 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Gilts Table 31. Significant Companies of Sows Table 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application (2021-2026) Table 41. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application (2027-2032) Table 42. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2026) Table 45. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2027-2032) Table 47. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Region (2021-2026) Table 50. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Region (2027-2032) Table 52. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 57. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2027-2032) Table 60. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Bioveta Company Information Table 65. Bioveta Business Overview Table 66. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 68. Bioveta Recent Development Table 69. Boehringer Ingelheim Company Information Table 70. Boehringer Ingelheim Business Overview Table 71. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 73. Boehringer Ingelheim Recent Development Table 74. CAVAC Company Information Table 75. CAVAC Business Overview Table 76. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 78. CAVAC Recent Development Table 79. Ceva Santé Animale Company Information Table 80. Ceva Santé Animale Business Overview Table 81. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 83. Ceva Santé Animale Recent Development Table 84. HIPRA Company Information Table 85. HIPRA Business Overview Table 86. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 88. HIPRA Recent Development Table 89. Jinyu Bio-Technology Company Information Table 90. Jinyu Bio-Technology Business Overview Table 91. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 93. Jinyu Bio-Technology Recent Development Table 94. Sinopharm Animal Health Co., Ltd Company Information Table 95. Sinopharm Animal Health Co., Ltd Business Overview Table 96. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 98. Sinopharm Animal Health Co., Ltd Recent Development Table 99. Zoetis Company Information Table 100. Zoetis Business Overview Table 101. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 103. Zoetis Recent Development Table 104. Harbin Pharmaceutical Group Company Information Table 105. Harbin Pharmaceutical Group Business Overview Table 106. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 108. Harbin Pharmaceutical Group Recent Development Table 109. Merck Company Information Table 110. Merck Business Overview Table 111. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 113. Merck Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 117. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Image Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (K Units) Figure 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. CH-1R Strain Image Figure 10. PC Strain Image Figure 11. Others Image Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Type (2021-2032) Figure 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type (2021-2032) Figure 18. Gilts Image Figure 19. Sows Image Figure 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • CH-1R Strain
  • PC Strain
  • Others
Applications
  • Gilts
  • Sows
Companies covered
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva Santé Animale
  • HIPRA
  • Jinyu Bio-Technology
  • Sinopharm Animal Health Co., Ltd
  • Zoetis
  • Harbin Pharmaceutical Group
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
  1. 2.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 2.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Company
  1. 3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Ranking (2024-2026)
  6. 3.6 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Product Type and Application
  8. 3.8 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  1. 4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Type Introduction
  2. 4.1.1 CH-1R Strain
  3. 4.1.2 PC Strain
  4. 4.1.3 Others
  5. 4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type
  6. 4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type
  10. 4.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Type (2021-2032)
  12. 4.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type (2021-2032)
5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  1. 5.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Application Introduction
  2. 5.1.1 Gilts
  3. 5.1.2 Sows
  4. 5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application
  5. 5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application
  9. 5.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application (2021-2032)
6 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Regional Sales and Value Analysis
  1. 6.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032)
  5. 6.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Country, 2025 VS 2032
7 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032)
  6. 7.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bioveta
  2. 8.1.1 Bioveta Company Information
  3. 8.1.2 Bioveta Business Overview
  4. 8.1.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 8.1.5 Bioveta Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 CAVAC
  14. 8.3.1 CAVAC Company Information
  15. 8.3.2 CAVAC Business Overview
  16. 8.3.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 8.3.5 CAVAC Recent Developments
  19. 8.4 Ceva Santé Animale
  20. 8.4.1 Ceva Santé Animale Company Information
  21. 8.4.2 Ceva Santé Animale Business Overview
  22. 8.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 8.4.5 Ceva Santé Animale Recent Developments
  25. 8.5 HIPRA
  26. 8.5.1 HIPRA Company Information
  27. 8.5.2 HIPRA Business Overview
  28. 8.5.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 8.5.5 HIPRA Recent Developments
  31. 8.6 Jinyu Bio-Technology
  32. 8.6.1 Jinyu Bio-Technology Company Information
  33. 8.6.2 Jinyu Bio-Technology Business Overview
  34. 8.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 8.6.5 Jinyu Bio-Technology Recent Developments
  37. 8.7 Sinopharm Animal Health Co., Ltd
  38. 8.7.1 Sinopharm Animal Health Co., Ltd Company Information
  39. 8.7.2 Sinopharm Animal Health Co., Ltd Business Overview
  40. 8.7.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 8.7.5 Sinopharm Animal Health Co., Ltd Recent Developments
  43. 8.8 Zoetis
  44. 8.8.1 Zoetis Company Information
  45. 8.8.2 Zoetis Business Overview
  46. 8.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 8.8.5 Zoetis Recent Developments
  49. 8.9 Harbin Pharmaceutical Group
  50. 8.9.1 Harbin Pharmaceutical Group Company Information
  51. 8.9.2 Harbin Pharmaceutical Group Business Overview
  52. 8.9.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 8.9.5 Harbin Pharmaceutical Group Recent Developments
  55. 8.10 Merck
  56. 8.10.1 Merck Company Information
  57. 8.10.2 Merck Business Overview
  58. 8.10.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 8.10.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 9.1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Mode & Process
  6. 9.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  9. 9.2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst